Relay Therapeutics, Inc.
RLAY
Revenue
10.01M
▲10.01M▲1000800.00%
3 Months ChangeAssets
772.55M
▼-68.89M▼-8.19%
3 Months ChangeLiabilities
90.81M
▼-4.87M▼-5.09%
3 Months ChangeFree Cash Flow
-52.10M
▲16.94M▲24.54%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-11
Form 8-K
ID: 0001193125-24-217296
2024-09-09
Form 8-K
ID: 0000950170-24-104557
2024-08-06
Form 10-Q
ID: 0000950170-24-091837
2024-08-06
Form 8-K
ID: 0000950170-24-091802
2024-07-16
Form 8-K
ID: 0000950170-24-083928
2024-06-06
Form 8-K
ID: 0000950170-24-069674
2024-06-03
Form 8-K
ID: 0000950170-24-067952
2024-05-02
Form 10-Q
ID: 0000950170-24-052135
2024-05-02
Form 8-K
ID: 0000950170-24-052110
2024-02-22
Form 8-K
ID: 0000950170-24-018763